News

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
12.03.2025 • News

BASF Signs Offtake Agreement with Braven for Recycled Feedstock

BASF and Braven Environmental, a market leader in advanced recycling, have signed a supply agreement for Braven PyChem. This recycled feedstock, derived from mixed plastic waste, will partially replace fossil resources at the BASF TotalEnergies Petrochemical (BTP) facility in Port Arthur, Texas, US, the companies said. Under the agreement, Braven will supply BASF from a multi-unit facility that it plans to build in Texarkana, Texas.

Photo
11.03.2025 • News

Sun Pharma to Acquire Checkpoint Therapeutics

Indian generic drug maker Sun Pharma agreed to acquire US immunotherapy and targeted oncology company Checkpoint Therapeutics for an upfront value of $355 million. The transaction is expected to be completed in the second quarter of 2025 and is subject to customary closing conditions.

Photo
11.03.2025 • News

Syngene Acquires its First US Manufacturing Facility

Syngene, a global contract research, development, and manufacturing organization (CRDMO), recently announced the acquisition of its first biologics site in the USA – fitted with multiple monoclonal antibody (mAbs) manufacturing lines.

Photo
10.03.2025 • News

Axplora Expands Capabilities at Le Mans Site

Axplora, an API small molecule and ADC (antibody-drug conjugate) manufacturer, is strengthening its position in the commercial manufacturing ADCs by launching a cutting-edge payload manufacturing workshop at its Le Mans site (France).

Photo
07.03.2025 • News

Rio Tinto Completes Acquisition of Arcadium Lithium

Rio Tinto has completed the $6.7 billion acquisition of Arcadium Lithium and is now the parent company of Arcadium Lithium, which will be renamed Rio Tinto Lithium and will also include the Rincon Lithium Project.

Photo
06.03.2025 • News

CordenPharma Expands Peptide Manufacturing Platform in Switzerland

Contract development and manufacturing organization (CDMO) CordenPharma has finalized plans to establish a new peptide manufacturing facility in Switzerland located at Getec Park in Muttenz near Basel. This investment is part of the company’s growth initiatives with a more than €1 billion strategic investment in peptide development and manufacturing.

Photo
06.03.2025 • News

ADNOC and OMV to Create Global Polyolefins Group

OMV and ADNOC agreed to combine their Borealis and Borouge shareholdings into Borouge Group International. ADNOC has also signed a share purchase agreement with Nova Chemicals, an indirect wholly owned subsidiary of Mubadala Investment Company, to acquire 100% of Nova Chemicals for an enterprise value of $13.4 billion. In addition, ADNOC and OMV have agreed for Borouge Group International to take over Nova Chemicals after closing.

Photo
04.03.2025 • News

AbbVie Teams up with Gubra to Develop Obesity Treatment

The US pharmaceutical giant AbbVie and Danish biotechnology company Gubra, specializing in preclinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases, signed a license agreement to develop GUB014295, a potential best-in-class, long-acting amylin analog for the treatment of obesity.

Photo
03.03.2025 • News

Toray Opens R&D Center in Taiwan for Semiconductors

Toray Industries has opened the Toray Taiwan Technical Center. This new facility aims to enhance research and development in advanced semiconductor technologies and materials, and provide technical services in the Taiwan market, which plays a significant role in the global semiconductor supply chain.

Photo
26.02.2025 • News

European Chemical Industry Becoming Extinct

Ahead of the unveiling of the EU’s Clean Industrial Deal, Ineos Chairman and CEO, Sir Jim Ratcliffe, authored an open letter to emphasize the importance of supportive political decisions and measures for the European industry. Releasing the open letter, Ineos stated: “A year on from the signing of ‘The Antwerp Declaration for a European Industrial Deal’ we have not seen the action necessary to stem the decline of European industry. Ineos has continued to invest in Europe; however, it is now an exception in a landscape of deindustrialization and closures.” Please read the complete open letter below:

Photo
26.02.2025 • News

Granules India Buys Swiss CDMO Senn Chemicals

Indian pharmaceutical company Granules India has agreed to acquire Senn Chemicals, a Swiss-based contract development and manufacturing organization (CDMO) specializing in peptides. The closing of the deal, which is subject to certain conditions, is expected to occur in the first half of 2025. Financial details of the transaction were not disclosed.

Photo
25.02.2025 • News

Air Products to Exit Three US-Based Projects

As part of a review initiated by Air Products’ newly-elected board of directors and CEO, the company decided to exit three projects in the US. As a result, Air Products expects to record a pre-tax charge not to exceed $3.1 billion in its fiscal 2025 second quarter, primarily to write down assets and terminate contractual commitments.

Photo
25.02.2025 • News

Symrise and Hofseth BioCare Partner on Marine Ingredients

German flavor and fragrance company Symrise has signed a strategic partnership with Hofseth BioCare (HBC), a Norwegian manufacturer of salmon-based ingredients for the human health and pet nutrition markets. With this partnership, Symrise wants to expand its presence in the health sector with clinically proven marine ingredients, the company said.

Photo
24.02.2025 • News

Nouryon Doubles Capacity of Chromatography Media in Sweden

Nouryon plans to expand its chromatography media manufacturing facility in Bohus, Sweden, doubling the site’s capacity. Construction will begin in early 2025, and the start of production is expected in early 2027, the company said.

Photo
20.02.2025 • News

Sanofi and CD&R Sign Share Purchase Agreement for Opella

Following completion of the required social and corporate procedures, Sanofi and CD&R have signed the share purchase agreement for the sale of a 50% controlling stake in its consumer health business Opella to US private equity firm Clayton Dubilier & Rice (CD&R).

Photo
20.02.2025 • News

Global Leaders Launch Innovative Circularity Pilot

The Global Impact Coalition (GIC), a CEO-led collaborative platform originally incubated at the World Economic Forum, launches the world’s first Automotive Plastics Circularity pilot together with seven global leaders in the chemical and recycling industries.

Photo
14.02.2025 • News

LG Chem Launches Production of Bio-Acrylic Acid

South Korean chemicals group LG Chem plans to start production of bio-acrylic acid in the second quarter of this year. Initial production capacity will be 100 metric tons (MT) per year, with plans to expand as demand for environmentally friendly resources grows.

Photo
13.02.2025 • News

Gevo and Axens Broaden their SAF Partnership

US clean technology company Gevo and French technology provider Axens have formed a new strategic alliance to accelerate development and commercialization of sustainable aviation fuel (SAF) using the ethanol-to-jet (ETJ) pathway.

Photo
12.02.2025 • News

Fujifilm Ramps up Capacity for Semiconductor Materials in Belgium

Fujifilm plans to invest approximately €25 million to install new production facilities for chemical mechanical planarization (CMP) slurries, which are used in advanced semiconductors, as well as enhance existing facilities for photolithography-related materials at its site in Antwerp, Belgium.

13509 more News

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.